Nasdaq
MLTX
MoonLake Immunotherapeutics
- Health Care
- Listed 2020
- 1 day
- +2.7%
- 1 month
- −5.8%
- 1 year
- −65.8%
$18.03 · Mkt cap $1.33B
At the 6 Aug 2026 close
Nasdaq
MoonLake Immunotherapeutics
$18.03 · Mkt cap $1.33B
At the 6 Aug 2026 close
MoonLake Immunotherapeutics trades under the ticker MLTX on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2020. Its market capitalisation is $1.33B. The last closing price was $18.03, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −65.8%, and −5.8% over the past month. Returns are price returns and exclude dividends.
This page exists because MLTX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.